120 related articles for article (PubMed ID: 2298534)
1. Studies on the ocular pharmacology of prostaglandin D2.
Woodward DF; Hawley SB; Williams LS; Ralston TR; Protzman CE; Spada CS; Nieves AL
Invest Ophthalmol Vis Sci; 1990 Jan; 31(1):138-46. PubMed ID: 2298534
[TBL] [Abstract][Full Text] [Related]
2. Further studies on ocular responses to DP receptor stimulation.
Woodward DF; Spada CS; Hawley SB; Williams LS; Protzman CE; Nieves AL
Eur J Pharmacol; 1993 Jan; 230(3):327-33. PubMed ID: 8440310
[TBL] [Abstract][Full Text] [Related]
3. Effects of prostaglandin D2 and its analogues on intraocular pressure in rabbits.
Goh Y; Nakajima M; Azuma I; Hayaishi O
Jpn J Ophthalmol; 1988; 32(4):471-80. PubMed ID: 3236567
[TBL] [Abstract][Full Text] [Related]
4. Effects of a selective DP receptor agonist (BW 245C) and antagonist (BW A868C) on the canine colonic epithelium: an argument for a different DP receptor?
Rangachari PK; Betti PA; Prior ET; Roberts LJ
J Pharmacol Exp Ther; 1995 Nov; 275(2):611-7. PubMed ID: 7473146
[TBL] [Abstract][Full Text] [Related]
5. Prostaglandin D2 inhibits prostaglandin E2-induced allodynia in conscious mice.
Minami T; Okuda-Ashitaka E; Mori H; Ito S; Hayaishi O
J Pharmacol Exp Ther; 1996 Sep; 278(3):1146-52. PubMed ID: 8819497
[TBL] [Abstract][Full Text] [Related]
6. Effects of prostaglandin D2, 15-deoxy-Delta12,14-prostaglandin J2, and selective DP1 and DP2 receptor agonists on pulmonary infiltration of eosinophils in Brown Norway rats.
Almishri W; Cossette C; Rokach J; Martin JG; Hamid Q; Powell WS
J Pharmacol Exp Ther; 2005 Apr; 313(1):64-9. PubMed ID: 15590767
[TBL] [Abstract][Full Text] [Related]
7. In-vivo activity and enzymatic hydrolysis of novel prostaglandin F2 alpha prodrugs in ocular tissues.
Woodward DF; Chan MF; Cheng-Bennett A; Wheeler LA; Chen G; Burke JA; Kharlamb A; Lai RK; Shan T
Exp Eye Res; 1996 Oct; 63(4):411-23. PubMed ID: 8944548
[TBL] [Abstract][Full Text] [Related]
8. Transformation of prostaglandin D2 to isomeric prostaglandin F2 compounds by human eosinophils. A potential mast cell-eosinophil interaction.
Parsons WG; Roberts LJ
J Immunol; 1988 Oct; 141(7):2413-9. PubMed ID: 3139758
[TBL] [Abstract][Full Text] [Related]
9. Prostaglandin F2 alpha effects on intraocular pressure negatively correlate with FP-receptor stimulation.
Woodward DF; Burke JA; Williams LS; Palmer BP; Wheeler LA; Woldemussie E; Ruiz G; Chen J
Invest Ophthalmol Vis Sci; 1989 Aug; 30(8):1838-42. PubMed ID: 2759797
[TBL] [Abstract][Full Text] [Related]
10. Effects of prostaglandin D2 and its analogue, BW245C, on intraocular pressure in humans.
Nakajima M; Goh Y; Azuma I; Hayaishi O
Graefes Arch Clin Exp Ophthalmol; 1991; 229(5):411-3. PubMed ID: 1937072
[TBL] [Abstract][Full Text] [Related]
11. The role of prostanoid TP- and DP-receptors in the bronchoconstrictor effect of inhaled PGD2 in anaesthetized guinea-pigs: effect of the DP-antagonist BW A868C.
Hamid-Bloomfield S; Payne AN; Petrovic AA; Whittle BJ
Br J Pharmacol; 1990 Aug; 100(4):761-6. PubMed ID: 2119842
[TBL] [Abstract][Full Text] [Related]
12. Differential modulation of human basophil functions through prostaglandin D2 receptors DP and chemoattractant receptor-homologous molecule expressed on Th2 cells/DP2.
Yoshimura-Uchiyama C; Iikura M; Yamaguchi M; Nagase H; Ishii A; Matsushima K; Yamamoto K; Shichijo M; Bacon KB; Hirai K
Clin Exp Allergy; 2004 Aug; 34(8):1283-90. PubMed ID: 15298571
[TBL] [Abstract][Full Text] [Related]
13. Responses of intraocular pressure and the pupil of feline eyes to prostaglandin EP1 and FP receptor agonists.
Bhattacherjee P; Williams BS; Paterson CA
Invest Ophthalmol Vis Sci; 1999 Nov; 40(12):3047-53. PubMed ID: 10549672
[TBL] [Abstract][Full Text] [Related]
14. Prostaglandin D2 receptor D-type prostanoid receptor 2 mediates eosinophil trafficking into the esophagus.
Zhang S; Wu X; Yu S
Dis Esophagus; 2014 Aug; 27(6):601-6. PubMed ID: 24165271
[TBL] [Abstract][Full Text] [Related]
15. 9 alpha,11 beta-prostaglandin F2, a novel metabolite of prostaglandin D2 is a potent contractile agonist of human and guinea pig airways.
Beasley CR; Robinson C; Featherstone RL; Varley JG; Hardy CC; Church MK; Holgate ST
J Clin Invest; 1987 Mar; 79(3):978-83. PubMed ID: 3469218
[TBL] [Abstract][Full Text] [Related]
16. The pruritogenic and inflammatory effects of prostanoids in the conjunctiva.
Woodward DF; Nieves AL; Hawley SB; Joseph R; Merlino GF; Spada CS
J Ocul Pharmacol Ther; 1995; 11(3):339-47. PubMed ID: 8590266
[TBL] [Abstract][Full Text] [Related]
17. Marked differential effects of prostanoid metabolites on rabbit intraocular pressure.
Woodward DF; Williams LS; Chen J
Ophthalmic Res; 1989; 21(6):428-35. PubMed ID: 2626239
[TBL] [Abstract][Full Text] [Related]
18. A comparative study of the prostanoid receptor profile of 9 alpha 11 beta-prostaglandin F2 and prostaglandin D2.
Giles H; Bolofo ML; Lydford SJ; Martin GR
Br J Pharmacol; 1991 Oct; 104(2):541-9. PubMed ID: 1665742
[TBL] [Abstract][Full Text] [Related]
19. Effects of topically applied prostaglandin F2 alpha tromethamine salt on glaucomatous human eyes.
Erkiliç K; Ekinciler OF; Mirza GE; Doğan H; Cagil N
Int J Clin Pharmacol Res; 1996; 16(2-3):51-5. PubMed ID: 9063756
[TBL] [Abstract][Full Text] [Related]
20. The effect of prostaglandin F2 alpha on intraocular pressure in normotensive human subjects.
Lee PY; Shao H; Xu LA; Qu CK
Invest Ophthalmol Vis Sci; 1988 Oct; 29(10):1474-7. PubMed ID: 3170119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
